Male Fertility Challenges: What You Need to Know and What You Can Do About It

Key Takeaways

• Male factors contribute to roughly 40-50% of all infertility cases, yet evaluation often defaults to female-partner testing first.
• Sperm count, motility, morphology, and DNA integrity all matter; standard semen analysis can miss DNA fragmentation that affects unexplained infertility.
• Exogenous testosterone (TRT) suppresses sperm production; clomiphene, hCG, gonadorelin, and selected peptides can preserve fertility in men needing hormone support.
• Roughly half of male infertility cases are treatable or reversible when the underlying cause is identified through comprehensive evaluation.
• Lifestyle factors (sleep, weight, heat exposure, alcohol, stress, environmental toxins) meaningfully affect semen quality within one to two spermatogenic cycles.

Infertility is still often framed as something that happens to women. The appointments, the testing, the conversations frequently begin with her. But male factors contribute to roughly 40 to 50 percent of all infertility cases according to data from the National Institutes of Health and the American Society for Reproductive Medicine. Most patients seeking evaluation are men in their late 20s through early 40s, though the same workup applies at any age when fertility is a goal.

Male infertility rarely announces itself with obvious symptoms. Most men do not realize there is an issue until their partner has already been through months or years of evaluation. At Venus Integrative Medical Center (VIMC) in Mesa, Arizona, the approach to male fertility starts with the root cause: hormonal, metabolic, structural, and lifestyle factors that influence sperm production, sperm quality, and reproductive function. The team evaluates the full picture and coordinates with trusted urologists and reproductive specialists when additional procedures are indicated.

How Male Fertility Actually Works

Male fertility depends on the continuous production, maturation, and delivery of healthy sperm. The process, called spermatogenesis, takes roughly 72 to 74 days from start to finish and unfolds in the testes under the direction of the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus signals the pituitary to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). FSH drives sperm production directly. LH stimulates testosterone production in the Leydig cells, and that testosterone supports spermatogenesis locally. Sperm mature in the epididymis and travel through the vas deferens during ejaculation. A disruption anywhere along this chain can reduce count, quality, or delivery.

Common Sperm Issues That Affect Fertility

When most people hear "male infertility," they think of sperm count. Count matters, but it is only one piece. The World Health Organization 6th Edition Laboratory Manual defines a normal sperm concentration as 15 million or more per milliliter of semen. Beyond count, three additional parameters matter:

• Motility: the ability of sperm to swim forward effectively. Poor motility (asthenozoospermia) means sperm may never reach the egg even when adequate numbers are present.
• Morphology: the shape and structural integrity of sperm. A high percentage of abnormally shaped sperm can reduce fertilization success.
• DNA integrity: sperm DNA fragmentation is increasingly recognized as a factor in unexplained infertility and recurrent pregnancy loss, even when standard parameters look normal.

Low sperm count (oligospermia) and absent sperm (azoospermia) are two of the more commonly diagnosed conditions. Azoospermia can be obstructive, meaning sperm are produced but blocked from entering the ejaculate, or non-obstructive, meaning testicular production itself is inadequate. Distinguishing the two matters because treatment paths are completely different.

Hormones and Male Fertility: The Testosterone Connection

This is where VIMC's approach becomes particularly relevant. Hormonal evaluation is not optional in male fertility care; it is foundational. Testosterone plays a direct role in spermatogenesis, but the testosterone that matters most for sperm production is intratesticular testosterone, produced locally in the testes and many times higher than the level measured in a standard blood draw. When the HPG axis is disrupted, both systemic and local testosterone decline, and sperm production follows.

The most important clinical point for men reading this: exogenous testosterone therapy (TRT) suppresses the HPG axis and can significantly reduce or eliminate sperm production. This is not a rare side effect; it is the expected physiological response. Testosterone administered from an outside source signals the brain to stop producing FSH and LH, and without those signals, the testes wind down spermatogenesis. A 2019 paper in World Journal of Men's Health (Patel et al.) made the case explicitly: testosterone behaves as a contraceptive and should not be used in men who desire fertility.

This does not mean testosterone optimization and fertility are mutually exclusive. Alternatives such as clomiphene citrate, human chorionic gonadotropin (hCG), and certain peptide protocols (including gonadorelin, with kisspeptin emerging when FDA-approved for compounding) can support testosterone levels while preserving the HPG signaling that sperm production requires. VIMC evaluates fertility status before initiating any testosterone protocol and builds a plan that accounts for both goals. Beyond testosterone, the workup includes FSH, LH, prolactin, estradiol, and thyroid function; each can independently affect fertility.

Structural and Anatomical Causes

Not all male fertility issues are hormonal. Physical abnormalities in the reproductive tract can impede sperm production or delivery, and many are correctable. Varicocele is the most common surgically correctable cause of male infertility. It involves enlarged veins in the scrotum that elevate local temperature and impair sperm production. The American Urological Association estimates varicocele is present in roughly 35 to 40 percent of men evaluated for primary infertility. Surgical repair (varicocelectomy) or embolization has been shown to improve semen parameters and pregnancy rates.

Obstructions in the vas deferens or epididymis, whether from prior surgery, infection, or congenital absence, can prevent sperm from reaching the ejaculate and may require microsurgical repair or sperm retrieval coordinated with a reproductive specialist. Undescended testes (cryptorchidism), if not corrected in childhood, can result in long-term impairment of sperm production due to the temperature sensitivity of spermatogenesis. VIMC coordinates imaging and surgical evaluation with trusted urological partners when structural causes are suspected.

Immunological factors are less common but worth screening when standard testing does not explain the picture. Anti-sperm antibodies can develop after testicular injury, surgery (including vasectomy reversal), or infection, and may impair sperm function or fertilization. Testing is typically ordered through reproductive endocrinology when the clinical picture suggests an immune component.

Lifestyle and Environmental Factors

Lifestyle factors exert measurable influence on sperm quality. Published research, summarized in a 2018 Arab Journal of Urology review by Durairajanayagam, supports the following associations:

• Tobacco and cannabis: linked to reduced sperm count, motility, and morphology, with nicotine increasing oxidative stress in sperm cells.
• Alcohol: moderate to heavy use lowers testosterone production and impairs spermatogenesis.
• Obesity: associated with hormonal disruption, including elevated estradiol and reduced testosterone.
• Heat exposure: frequent sauna or hot tub use, tight clothing, or prolonged laptop use on the lap can elevate scrotal temperature enough to impair sperm production.
• Environmental toxins: pesticides, phthalates, BPA, and heavy metals are recognized endocrine disruptors that can damage sperm DNA.
• Chronic stress: disrupts the HPG axis, lowers testosterone, and is associated with decreased sperm concentration and motility.

Many of these factors are modifiable. Lifestyle optimization is a core component of VIMC's approach, and meaningful changes in semen parameters often appear within one to two spermatogenic cycles, roughly three to six months.

Signs and Symptoms: When to Seek Evaluation

Most men with fertility issues experience no symptoms. Sperm quality can decline significantly without visible signs. Certain indicators warrant earlier evaluation: difficulty conceiving after 12 months of unprotected intercourse (or 6 months if the partner is 35 or older), low libido or erectile dysfunction, history of testicular injury, surgery, or undescended testes, known hormonal conditions, prior use of exogenous testosterone or anabolic steroids, chronic illness or autoimmune disease, prior chemotherapy or radiation, or recurrent pregnancy loss in a partner when no clear female factor has been identified.

How VIMC Evaluates Male Fertility

VIMC performs comprehensive hormonal and metabolic evaluation in-office and coordinates semen analysis and imaging with trusted lab and specialist partners. A typical workup includes:

• Complete hormone panel: total and free testosterone, FSH, LH, prolactin, estradiol, SHBG, DHEA-S.
• Thyroid function: TSH, Free T3, Free T4, and thyroid antibodies when clinically indicated.
• Metabolic markers: fasting insulin, HbA1c, lipid panel, hs-CRP, homocysteine.
• Micronutrient status: zinc, selenium, vitamin D, B12, folate, all of which influence sperm production and quality.
• Semen analysis: coordinated with a certified andrology laboratory for sperm count, motility, morphology, and DNA fragmentation testing when warranted.

This layered approach builds the full biological context rather than treating any single number in isolation.

Treatment: What is Treatable and How VIMC Approaches Care

Research suggests nearly half of male infertility cases are treatable or reversible when the underlying cause is identified. VIMC's approach moves in stages. First, the comprehensive evaluation pinpoints the specific factors at play. Second, foundation work addresses correctable inputs: targeted supplementation (zinc, selenium, CoQ10, vitamin D), dietary changes, stress management, toxin reduction, and sleep optimization. These often produce measurable improvement within one to two spermatogenic cycles.

Third, targeted treatment addresses specific findings. For hormonal imbalances, clomiphene citrate to stimulate endogenous testosterone and FSH, hCG to support intratesticular testosterone, or carefully selected peptide protocols may be appropriate. For men currently on TRT who wish to preserve or restore fertility, a transition plan that maintains hormonal stability while reactivating spermatogenesis is built individually. Fourth, coordination and referral are initiated when structural correction, advanced reproductive techniques, or specialist evaluation are needed. VIMC coordinates directly with urologists and reproductive endocrinologists in the East Valley to ensure continuity, whether varicocele repair, surgical sperm retrieval, or assisted reproductive technology (IUI, IVF, ICSI) becomes the right path.

Your Fertility is Worth Investigating

If you have been trying to conceive without success, or if questions about how hormones, lifestyle, or testosterone therapy may be affecting your reproductive health remain unanswered, the right evaluation can bring real clarity. Male infertility is common, frequently treatable, and best addressed with thorough root-cause work rather than assumptions or delayed testing.